Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Biotricity Inc BTCY

Biotricity Inc. is a medical technology company focused on biometric data monitoring and diagnostic solutions. The Company developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. It has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.


OTCQB:BTCY - Post by User

Post by stargazer1on Jul 20, 2023 12:25am
237 Views
Post# 35549199

Share blasted off in after-hours trading

Share blasted off in after-hours trading
BTCY did a 1 for 6 reverse split on July 3rd. Its price was $0.50 and after the reverse split, it was $3. It quickly climbed to $3.28, but, as is usual after a reverse split, people were used to seeing it at a much lower price, and in a few days, it fell to $2.35. It held that price and then started climbing. On July 14th it passed the $3 level and closed at $3.05, but then started slowly edging down and today, July 19th it closed at $2.92. 
 
But wow. In after-hours trading, it started taking off and closed WAY ABOVE its post-reverse split high of $3.28:
 
BTCY
$3.36 +$0.44 (+15.07%)
After hours: 07:52 PM EDT 07/19/23
 
That may not hold in tomorrow's trading, but over the last year, every press release has shown that the company is on a very very strong growth trend as it continuously innovates its product. Ours is the ONLY COMPANY with advanced continuous cardiac monitoring that the doctors can directly access. Cardiac doctors throughout the country are signing up with the company and the list of patients is growing exponentially. Soon the company will be expanding to other countries.
 
Our company is still in its infancy. It has YEARS of growth ahead of it. With the reverse split, its share count is just 8.75 million shares. And, as I said, its share price blasted upward in after-hours trading. It may back off, but buying shares anywhere in this price range will be a no-brainer. (Does that mean that anybody that buys here is a zombie?}
 
Be interesting to see what it does Thursday 7/20/23.
<< Previous
Bullboard Posts
Next >>